MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
the issuance of...
$17,915K
Net proceeds from
the exercise of...
$5,755K
Net cash provided by
financing activities
$23,640K
Canceled cashflow
$30K
Net increase
(decrease) in cash, cash...
$15,649K
Canceled cashflow
$7,991K
Payments to repurchase
shares withheld for...
$30K
Stock-based compensation
$481K
Accounts payable
$183K
Accrued expenses
$143K
Depreciation and
amortization
$3K
Net cash (used in)
operating activities
-$7,979K
Net cash (used in)
provided by investing...
-$12K
Canceled cashflow
$810K
Other income, net
$522K
Net loss
-$8,698K
Cash paid for
purchase of property and...
$12K
Canceled cashflow
$522K
Prepaid expenses and
other assets
$91K
Total operating
expenses
$9,220K
Research and development
$4,618K
General and
administrative
$4,602K
Back
Back
Cash Flow
source: myfinsight.com
Phio Pharmaceuticals Corp. (PHIO)
Phio Pharmaceuticals Corp. (PHIO)